-
Collecting Patient Preference Information (PPI) in In-Trial/Exit Interviews: Current Perspectives and Future Considerations
Sep 9, 2025, 16:22 PM -
Fragmentation in Access Pathways: A Review of HTA and Decision-Making Processes for Medicines in Finland
Sep 9, 2025, 16:22 PM -
The Socioeconomic Value of Adult Respiratory Immunization Programs in France: Can Improved Coverage Unlock Missed Gains?
Sep 9, 2025, 16:22 PM -
Patient Preferences for Type 2 Diabetes Mellitus (T2DM) Treatment: A Systematic Review of Discrete Choice Experiments Studies
Sep 9, 2025, 16:22 PM -
Dutch Cost Implications of Faricimab in Neovascular Age-Related Macular Degeneration: A Systematic Review of Treatment Interval and Injection Frequency
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis of Survival Outcomes in the First-Line Treatment of Unresectable or Metastatic Melanoma: Scoping Review of Methodology
Sep 9, 2025, 16:22 PM -
A Two-Stage Bayesian Approach for Real-World Cost-Effectiveness Analysis: Combining Inverse Probability Weighting With Gamma-Beta Regression Model
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Dostarlimab Plus Carboplatin-Paclitaxel in Primary Advanced or Recurrent Endometrial Cancer With Deficient Mismatch Repair (dMMR) and High Microsatellite Instability (MSI-H) in France
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Breast Cancer: A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Examination of Muscle Activity Among Aesthetic Sports Athletes
Sep 9, 2025, 16:22 PM -
Patient Perspectives on the Lifelong Impact of Preterm Birth in Chronic Respiratory Disease Care
Sep 9, 2025, 16:22 PM -
Methods for Incidence Progression Estimation in Partitioned Survival Analysis: Does the Chosen Method Matter?
Sep 9, 2025, 16:22 PM -
Implementing SISAQOL Recommendations: Insights From Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Chronic Kidney Disease in Type-2 Diabetes Patients: A Population-Based Descriptive Study
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Firstline Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review With Focus on the PD-L1 Negative Subgroup
Sep 9, 2025, 16:22 PM -
Real-World Outcomes and Economic Impact of Ribociclib in HR+/HER2- Advanced Breast Cancer: Evidence From the Portuguese REASSURE Cohort
Sep 9, 2025, 16:22 PM -
Overcoming Patient Access Barriers in Complex Conditions: Lessons From Schizophrenia for Broader Healthcare Applications
Sep 9, 2025, 16:22 PM -
Efficient and High-Quality Decision Making: An Exploration of Disease-Specific Reference Models at NICE
Sep 9, 2025, 16:22 PM -
Quantifying the Impact of Inconsistencies in Economic Modeling Assumptions: A Case Study in Metastatic Colorectal Cancer
Sep 9, 2025, 16:22 PM -
Economic Assessments of Rare Disease Drugs in France: Insights From CEESP Opinions Reviews
Sep 9, 2025, 16:22 PM